Tyra Biosciences (TYRA) News Today $21.67 +0.69 (+3.29%) (As of 11:31 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 Time Period Tyra Biosciences Announces Late-Breaking Oral Presentation on Preliminary Safety and Anti-Tumor Activity of TYRA-300 from SURF301 at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2024)October 11 at 8:00 AM | prnewswire.comTyra Biosciences (NASDAQ:TYRA) Stock Price Down 4.9% - What's Next?Tyra Biosciences (NASDAQ:TYRA) Shares Down 4.9% - Should You Sell?October 9 at 1:50 PM | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Stock Price Up 4.6% on Analyst UpgradeOctober 8 at 11:17 AM | americanbankingnews.comTyra Biosciences (NASDAQ:TYRA) Price Target Raised to $30.00 at HC WainwrightOctober 7, 2024 | americanbankingnews.comTyra Biosciences CEO sells shares worth $12,000October 5, 2024 | uk.investing.comTyra Biosciences (NASDAQ:TYRA) Stock Price Down 4.6% - What's Next?October 4, 2024 | americanbankingnews.comTyra Bioscience (TYRA) Receives a Buy from Piper SandlerOctober 3, 2024 | markets.businessinsider.comTyra Biosciences, Inc. (NASDAQ:TYRA) CEO Todd Harris Sells 500 SharesOctober 3, 2024 | insidertrades.comTyra Biosciences (NASDAQ:TYRA) Stock Price Down 4.6%Tyra Biosciences (NASDAQ:TYRA) Trading Down 4.6%October 2, 2024 | marketbeat.comTyra Biosciences, Inc. (NASDAQ:TYRA) Shares Bought by Perceptive Advisors LLCPerceptive Advisors LLC raised its stake in Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 50.5% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,007,367 shares of the company's stock after acquiring an additionSeptember 30, 2024 | marketbeat.comAmerican Century Companies Inc. Buys 145,346 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA)American Century Companies Inc. increased its holdings in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 582.9% in the second quarter, according to its most recent filing with the SEC. The fund owned 170,283 shares of the company's stock after acquiring an additional 145,346 sharesSeptember 28, 2024 | marketbeat.comEnsign Peak Advisors Inc Invests $3.05 Million in Tyra Biosciences, Inc. (NASDAQ:TYRA)Ensign Peak Advisors Inc purchased a new stake in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 190,557 shares of the company's stock, valuedSeptember 27, 2024 | marketbeat.comTodd Harris Sells 600 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) StockSeptember 26, 2024 | insidertrades.comAlly Bridge Group NY LLC Invests $4.23 Million in Tyra Biosciences, Inc. (NASDAQ:TYRA)Ally Bridge Group NY LLC bought a new position in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 264,660 shares of the company's stock, valued aSeptember 23, 2024 | marketbeat.comTyra Biosciences CEO sells over $394k in company stockSeptember 22, 2024 | investing.comTyra Biosciences, Inc. (NASDAQ:TYRA) CEO Todd Harris Sells 5,698 SharesSeptember 21, 2024 | insidertrades.comTyra Biosciences (NASDAQ:TYRA) Sets New 52-Week High After Analyst UpgradeTyra Biosciences (NASDAQ:TYRA) Sets New 1-Year High Following Analyst UpgradeSeptember 19, 2024 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Shares Gap Up to $20.55Tyra Biosciences (NASDAQ:TYRA) Shares Gap Up to $20.55September 16, 2024 | marketbeat.comTyra Biosciences names Doug Warner as new Chief Medical OfficerSeptember 12, 2024 | uk.investing.comTyra Biosciences (NASDAQ:TYRA) Stock Price Down 5.7%Tyra Biosciences (NASDAQ:TYRA) Stock Price Down 5.7%September 11, 2024 | marketbeat.comTyra Biosciences to Present at the 2024 Cantor Global Healthcare ConferenceSeptember 11, 2024 | prnewswire.comThe Schall Law Firm Has Launched An Inquiry Into Tyra Biosciences Inc For Securities Law Violations And Investors Are Urged To ContributeSeptember 11, 2024 | stockhouse.comTyra Biosciences Appoints Doug Warner, M.D., as Chief Medical OfficerSeptember 10, 2024 | prnewswire.comTyra Biosciences (NASDAQ:TYRA) Trading 3.2% Higher Tyra Biosciences (NASDAQ:TYRA) Trading Up 3.2%September 3, 2024 | marketbeat.comAn Inquiry Is Being Made Into Whether Tyra Biosciences Has Defrauded The Public And The Schall Law Firm Wants Shareholders To HelpSeptember 2, 2024 | stockhouse.comTyra Biosciences, Inc. (TYRA): One of Oppenheimer’s Top Stock Picks For the Next 12 MonthsAugust 27, 2024 | finance.yahoo.comTyra Biosciences, Inc. (TYRA) Stock Price, News, Quote & History - Yahoo FinanceAugust 25, 2024 | finance.yahoo.comTYRA Sep 2024 25.000 callAugust 24, 2024 | ca.finance.yahoo.comTyra Biosciences (NASDAQ:TYRA) Sees Large Volume IncreaseTyra Biosciences (NASDAQ:TYRA) Sees Unusually-High Trading VolumeAugust 22, 2024 | marketbeat.comTYRA Investors Have Opportunity to Join Tyra Biosciences, Inc. Securities Fraud Investigation with the Schall Law FirmAugust 21, 2024 | tmcnet.comTyra Biosciences (NASDAQ:TYRA) Stock Price Down 2.3%Tyra Biosciences (NASDAQ:TYRA) Trading Down 2.3%August 19, 2024 | marketbeat.comTYRA Sep 2024 20.000 call (TYRA240920C00020000)August 17, 2024 | finance.yahoo.comPiper Sandler Initiates Coverage of Tyra Biosciences (TYRA) with Overweight RecommendationAugust 16, 2024 | msn.comBuy Rating for Tyra Biosciences Backed by TYRA-300’s Potential and FGFR ExpertiseAugust 16, 2024 | markets.businessinsider.comTyra Biosciences (NASDAQ:TYRA) Hits New 1-Year High at $23.96Tyra Biosciences (NASDAQ:TYRA) Sets New 12-Month High at $23.96August 15, 2024 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Coverage Initiated by Analysts at Piper SandlerPiper Sandler assumed coverage on shares of Tyra Biosciences in a research note on Thursday. They set an "overweight" rating and a $33.00 price objective for the company.August 15, 2024 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Trading Up 7.1%Tyra Biosciences (NASDAQ:TYRA) Trading Up 7.1%August 13, 2024 | marketbeat.comTyra Biosciences, Inc. (NASDAQ:TYRA) Stake Boosted by Vanguard Group Inc.Vanguard Group Inc. grew its position in Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 18.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 899,800 shares of the company's stock after buying aAugust 13, 2024 | marketbeat.comAnalysts Set Expectations for Tyra Biosciences, Inc.'s Q3 2024 Earnings (NASDAQ:TYRA)Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) - Equities researchers at Wedbush boosted their Q3 2024 earnings per share estimates for Tyra Biosciences in a research report issued to clients and investors on Thursday, August 8th. Wedbush analyst R. Driscoll now forecasts that the company wilAugust 12, 2024 | marketbeat.comTyra Biosciences stock target raised, rating reiterated on study progressAugust 10, 2024 | uk.investing.comBuy Rating Backed by Promising Phase 1 Results and Potential of Tyra Bioscience’s Selective FGFR InhibitorsAugust 9, 2024 | markets.businessinsider.comWedbush Reaffirms Their Buy Rating on Tyra Bioscience (TYRA)August 9, 2024 | markets.businessinsider.comTyra Biosciences (NASDAQ:TYRA) Releases Quarterly Earnings Results, Beats Estimates By $0.09 EPSTyra Biosciences (NASDAQ:TYRA - Get Free Report) released its earnings results on Wednesday. The company reported ($0.32) earnings per share for the quarter, beating the consensus estimate of ($0.41) by $0.09.August 8, 2024 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Stock Rating Reaffirmed by WedbushWedbush restated an "outperform" rating and issued a $28.00 target price on shares of Tyra Biosciences in a research note on Thursday.August 8, 2024 | marketbeat.comOppenheimer Lowers Tyra Biosciences (NASDAQ:TYRA) Price Target to $25.00Oppenheimer decreased their target price on shares of Tyra Biosciences from $28.00 to $25.00 and set an "outperform" rating on the stock in a report on Thursday.August 8, 2024 | marketbeat.comTYRA Stock Earnings: Tyra Biosciences Beats EPS for Q2 2024August 8, 2024 | investorplace.comTyra Biosciences Reports Second Quarter 2024 Financial Results and HighlightsAugust 7, 2024 | prnewswire.comTyra Biosciences (NASDAQ:TYRA) Sets New 1-Year High at $22.05Tyra Biosciences (NASDAQ:TYRA) Sets New 12-Month High at $22.05July 23, 2024 | marketbeat.comLots Of Bullish Signals, But No Revenue Or Earnings From Tyra BiosciencesJuly 22, 2024 | seekingalpha.comVirginia General Assembly repeals VMSDEP language, veterans say it’s a ‘slight relief’July 21, 2024 | msn.com Get Tyra Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TYRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden’s Capital Gains Tax to Devastate Savings! (Ad)Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security. >> Get Your FREE Wealth Protection Guide << TYRA Media Mentions By Week TYRA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TYRA News Sentiment▼0.810.72▲Average Medical News Sentiment TYRA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TYRA Articles This Week▼92▲TYRA Articles Average Week Get Tyra Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TYRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RARE News BBIO News RNA News ADMA News BHVN News ACLX News IMVT News CRNX News CYBN News TGTX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TYRA) was last updated on 10/11/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredKamala’s tax plan is worse than you think—find out whyBuffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredCRUSHED: How Biden's Replacement Will Devastate Your 401(k)!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a ...Golden Crest | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tyra Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tyra Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.